SOPHiA GENETICS SA
NASDAQ:SOPH
Overview | Financials
Company Name | SOPHiA GENETICS SA |
Symbol | SOPH |
Currency | USD |
Price | 3.26 |
Market Cap | 213,122,826 |
Dividend Yield | 0% |
52-week-range | 2.7 - 7.37 |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Dr. Jurgi Camblong M.B.A., Ph.D. |
Website | https://www.sophiagenetics.com |
An error occurred while fetching data.
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD